PureHealth Declares AED 343 Million Dividend in Landmark First Year as Public Company

Middle East’s Largest Healthcare Group Rewards Shareholders with 20% of Net Profit, Signals Confidence in Growth Strategy
PureHealth Holding, the largest healthcare group in the Middle East, has announced the approval of its first-ever dividend distribution following a landmark year since its public listing on the Abu Dhabi Securities Exchange (ADX) in December 2023. The declaration comes after the company’s Annual General Assembly (AGM), where shareholders gave the green light for a dividend payout totaling AED 343 million for the 2024 financial year.

The approved dividend equates to AED 3.09 fils per share, representing 20% of PureHealth’s net profit for the year—an impressive milestone that highlights the Group’s commitment to creating shareholder value. “This dividend demonstrates the Group’s ability to generate strong returns and create value for shareholders whilst retaining its ability to execute on its ambitious growth plans including global expansion opportunities,” said Shaista Asif, Group Chief Executive Officer of PureHealth.

The announcement follows a robust financial performance in PureHealth’s first full year as a publicly traded entity. The Group reported revenues of AED 25.8 billion, EBITDA of AED 4.1 billion, and a net profit of AED 1.7 billion. These figures are supported by a strong balance sheet boasting a cash position of AED 11.9 billion and a conservative leverage ratio of just 0.1x, providing strategic flexibility for future investments and acquisitions.

PureHealth’s financial strength underpins its ambition for global expansion. As part of its international growth strategy, the Group recently acquired a 60% stake in Greece’s Hellenic Healthcare Group from global private equity firm CVC, which will retain a minority interest in the business. The acquisition reflects PureHealth’s focused efforts to extend its healthcare capabilities and global footprint, reinforcing its reputation as a regional leader with global aspirations.

The dividend announcement marks a pivotal moment in PureHealth’s journey, showcasing both its strong operational performance and its vision for long-term, sustainable growth. Following shareholder approval at the AGM, the last day for shareholders to be eligible for the dividend is April 17, 2025, with payment scheduled for May 8, 2025.

With a firm foundation and a clear roadmap, PureHealth continues to redefine the healthcare landscape across the Middle East and beyond, merging financial discipline with a bold expansion strategy to deliver lasting value to shareholders and communities alike.